MR Imaging-based Biomarker Development in Hemorrhagic Stroke Patients Including Brain Iron Quantification, Diffusion Tensor Imaging, and Phenomenon of Ultra-early Erythrolysis.
Publication/Presentation Date
5-1-2024
Abstract
This review article discusses the role of MR imaging-based biomarkers in understanding and managing hemorrhagic strokes, focusing on intracerebral hemorrhage (ICH) and aneurysmal subarachnoid hemorrhage. ICH is a severe type of stroke with high mortality and morbidity rates, primarily caused by the rupture of small blood vessels in the brain, resulting in hematoma formation. MR imaging-based biomarkers, including brain iron quantification, ultra-early erythrolysis detection, and diffusion tensor imaging, offer valuable insights for hemorrhagic stroke management. These biomarkers could improve early diagnosis, risk stratification, treatment monitoring, and patient outcomes in the future, revolutionizing our approach to hemorrhagic strokes.
Volume
34
Issue
2
First Page
215
Last Page
224
ISSN
1557-9867
Published In/Presented At
Bah, M. G., Dowlati, E., Fleigner, M., Koduri, S., Pandey, A., Lin, L. Y., Chenevert, T. L., Troost, J., Xi, G., Keep, R., & Chaudhary, N. (2024). MR Imaging-based Biomarker Development in Hemorrhagic Stroke Patients Including Brain Iron Quantification, Diffusion Tensor Imaging, and Phenomenon of Ultra-early Erythrolysis. Neuroimaging clinics of North America, 34(2), 215–224. https://doi.org/10.1016/j.nic.2024.01.001
Disciplines
Medicine and Health Sciences
PubMedID
38604706
Department(s)
Department of Surgery
Document Type
Article